Michelle Morand

Michelle Morand is the Co-Founder and CEO of CTOAM (Cancer Treatment Options & Management).1 As a Precision Cancer Advocacy Specialist, she plays a crucial role in advancing cancer care and treatment options for patients.2

Professional Background

Michelle has developed an extensive global network of researchers and healthcare providers, which she leverages to make innovative treatments and tests more accessible to cancer patients.1 Her work focuses on ensuring that cutting-edge cancer care options reach those who need them most.

Expertise and Contributions

Cancer Care Advocacy:: Michelle specializes in precision cancer advocacy, working to improve access to advanced treatment options for patients.2 She is passionate about the future of cancer care and believes it holds great promise for improved outcomes.

Treatment Access:: One of Michelle's key areas of expertise is helping patients navigate situations where their doctors may be reluctant to pursue certain treatments. She provides guidance on how to approach these challenges and advocate for access to potentially beneficial therapies.4

Media Presence

Michelle Morand actively shares her knowledge and insights through various media channels:

• She participates in podcast interviews, discussing topics related to cancer treatment and patient advocacy.3
• Michelle creates educational content, including short videos explaining concepts in cancer care and treatment options.24

Through her work at CTOAM and her advocacy efforts, Michelle Morand is dedicated to improving cancer care outcomes and empowering patients with knowledge and access to advanced treatment options.